Several other next-generation medications are also in development, each approaching weight management from different angles: Retatrutide is a new medication from Eli Lilly in trials that targets three hormones that control appetite and metabolism
Targeting the tumor microenvironment: removing obstruction to anticanc er immune responses and immunotherapy
Controversy persists regarding their effectiveness in reducing pain and improving the function
They help regulate processes such as cellular repair, metabolism, immune function, and tissue support
The goal is to inject into the muscle belly nearest the suspected injury, not directly into the tendon or ligament itself
Injectable GLP-1 RAs like liraglutide, semaglutide, and dulaglutide have been shown to significantly lower HbA1c and body weight in patients with T2DM